Ung T, Rutledge NS, Weiss AM, Esser-Kahn AP, Deak P. Cell-targeted vaccines: implications for adaptive immunity. Front Immunol. 2023 Aug 16;14:1221008. doi: 10.3389/fimmu.2023.1221008. PMID: 37662903; PMCID: PMC10468591.
Deak, P. Bradley Studnitzer, Trevor Ung, Rachel Steinhardt, Melody Swartz, Aaron Esser-Kahn. Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses. Cell Reports 41, (2022). https://doi.org/10.1016/j.celrep.2022.111563
Deak P, Knight HR, Esser-Kahn A. Robust tolerogenic dendritic cells via push/pull pairing of toll-like-receptor agonists and immunomodulators reduces EAE. Biomaterials. 2022 Jul;286:121571. doi: 10.1016/j.biomaterials.2022.121571. Epub 2022 May 11. PubMed PMID: 35597168.select
Deak P, Kimani F, Cassaidy B, Esser-Kahn A. Determining Whether Agonist Density or Agonist Number Is More Important for Immune Activation via Micoparticle Based Assay. Front Immunol. 2020;11:642. doi: 10.3389/fimmu.2020.00642. eCollection 2020. PubMed PMID: 32328073; PubMed Central PMCID: PMC7161694.select
Stefanick JF, Omstead DT, Ashley JD, Deak PE, Mustafaoglu N, Kiziltepe T, Bilgicer B. Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitro. J Control Release. 2019 Oct;311-312:190-200. doi: 10.1016/j.jconrel.2019.08.033. Epub 2019 Aug 29. PubMed PMID: 31473250.select
Deak PE, Kim B, Koh B, Qayum AA, Kiziltepe T, Kaplan MH, Bilgicer B. Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine Model. J Immunol. 2019 Jul 1;203(1):21-30. doi: 10.4049/jimmunol.1900225. Epub 2019 May 17. PubMed PMID: 31101666; PubMed Central PMCID: PMC6823631.select
Deak PE, Kim B, Adnan A, Labella M, De Las Vecillas L, Castells M, Bilgicer B. Nanoallergen platform for detection of platin drug allergies. J Allergy Clin Immunol. 2019 May;143(5):1957-1960.e12. doi: 10.1016/j.jaci.2019.01.010. Epub 2019 Jan 23. PubMed PMID: 30682456; PubMed Central PMCID: PMC6608568.select
Deak PE, Kim B, Abdul Qayum A, Shin J, Vitalpur G, Kloepfer KM, Turner MJ, Smith N, Shreffler WG, Kiziltepe T, Kaplan MH, Bilgicer B. Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen. Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8966-8974. doi: 10.1073/pnas.1820417116. Epub 2019 Apr 8. PubMed PMID: 30962381; PubMed Central PMCID: PMC6500160.select
Deak PE, Vrabel MR, Kiziltepe T, Bilgicer B. Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen Platform. Sci Rep. 2017 Jun 21;7(1):3981. doi: 10.1038/s41598-017-04268-6. PubMed PMID: 28638052; PubMed Central PMCID: PMC5479826.select
Deak PE, Vrabel MR, Pizzuti VJ, Kiziltepe T, Bilgicer B. Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulation. Exp Biol Med (Maywood). 2016 May;241(9):996-1006. doi: 10.1177/1535370216644533. Epub 2016 Apr 13. PubMed PMID: 27188517; PubMed Central PMCID: PMC4950352.select
Handlogten MW, Deak PE, Bilgicer B. Two-allergen model reveals complex relationship between IgE crosslinking and degranulation. Chem Biol. 2014 Nov 20;21(11):1445-51. doi: 10.1016/j.chembiol.2014.08.019. Epub 2014 Oct 9. PubMed PMID: 25308278; PubMed Central PMCID: PMC4254312.select
Handlogten MW, Stefanick JF, Deak PE, Bilgicer B. Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodies. Analyst. 2014 Sep 7;139(17):4247-55. doi: 10.1039/c4an00780h. PubMed PMID: 25006715.